• 1. Institute of Digestive Surgery, West China Hospital; 2. West China Health Hospital of Sichuan University; 3.West China School of Pharmacy, Sichuan University; Chengdu, Sichuan 610041, P. R. China;
ZHOU Zongguang., Email: wcums_q@sina.com
Export PDF Favorites Scan Get Citation

目的  评价康艾注射液辅助化学疗法(化疗)对直肠癌术后临床疗效、生活质量及其不良反应的影响。 方法  2010年4月-2011年2月收治的50例直肠癌术后化疗患者,随机分为试验组与对照组,每组25例。两组均采用FOLFOX方案化疗,在化疗同时,试验组予静脉滴注康艾注射液辅助治疗。连续治疗6个周期,比较两组临床疗效、生活质量及其不良反应情况。 结果  试验组治疗有效率为84%,对照组为88%,差异无统计学意义(P>0.05);两组生活质量改善率差异无统计学意义(P>0.05);试验组胃肠道反应、白细胞计数下降发生率低于对照组,差异有统计学意义(P<0.05)。 结论  康艾注射液用于直肠癌术后的辅助化疗可降低化疗的不良反应。

Citation: QIAO Jieqi,LI Feng,QIU Jinsong,ZHOU Zongguang.. Efficacy of Kangai Injection Combined with Chemotherapy for Postoperative Rectal Cancer Patients. West China Medical Journal, 2013, 28(9): 1420-1422. doi: 10.7507/1002-0179.20130445 Copy

Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved

  • Previous Article

    Expression of CRABPⅡ, E-FABP and Ki67 in Breast Invasive Ductal Carcinoma and Their Correlation
  • Next Article

    The Clinical Efficacy of Total Glucosides of Peony in the Treatment of Primary Sjögren’s Syndrome